Hims to Sell Lilly’s Zepbound Through Its Telehealth Platform

» Hims to Sell Lilly’s Zepbound Through Its Telehealth Platform




Hims & Hers Health Inc.’s shares jumped Tuesday after it said it was broadening its weight-loss offerings, adding access to brand name shots like Zepbound after previously focusing on cheaper versions made by compounding pharmacies.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *